A phase I/II dose-escalation multi-center study to evaluate the safety of infusion of natural killer cells or memory T cells as adoptive therapy in coronavirus pneumonia and/or lymphopenia: RELEASE study protocol.
I García-GarcíaP Guerra-GarcíaC FerrerasA M BorobiaA J CarcasJ Queiruga-ParadaJ L VicarioI MironesC SolanoC EguizabalB SoriaPérez-Martínez AntonioPublished in: Trials (2021)
ClinicalTrials.gov NCT04578210 . First Posted : October 8, 2020.